DCF — TEXAS HEALTH SOUTHWEST
Enterprise Value: $323.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$323.3M
Enterprise Value
$86.0M
PV of Cash Flows
$237.2M
PV of Terminal Value
$382.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $373.5M | $40.8M | 11.0% | $17.1M | $15.6M |
| Year 2 | $384.7M | $45.9M | 12.0% | $20.5M | $17.0M |
| Year 3 | $396.2M | $51.2M | 13.0% | $24.1M | $18.1M |
| Year 4 | $408.1M | $54.8M | 13.0% | $26.4M | $18.0M |
| Year 5 | $420.3M | $57.5M | 14.0% | $28.0M | $17.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $323.3M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$362.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.10428502953641014
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5